ShockWave Medical Boosts Guidance After Another Strong Quarter
ShockWave Medical (NASDAQ: SWAV), a medical device company focused on treating calcified plaque, reported its second-quarter earnings on Monday.
Revenue landed at $10 million for the quarter, which represented a 339% increase over the year-ago period. Management credited the huge gains to strong demand in both the U.S. and international markets, and raised full-year revenue guidance as a result.
Metric
Quelle Fool.com


